Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults

Lecture Room
National Academy of Sciences Building
2101 Constitution Avenue NW
Washington DC 20418

January 26, 2004: 9:00 a.m. to 5:00 p.m.
and
January 27, 2004: 8:30 a.m. to 1:00 p.m.

Louise Russell, Ph.D., Chair
Martin Brown, Ph.D. Co-Chair
Judith Wagner, Ph.D, IOM Staff Officer

The Workshop is Free and Open to the Public

Day 1

8:30- 9:00
Continental Breakfast, Lecture Room

9:00 – 9:30
Welcome and Introduction to the Workshop
Louise Russell, Workshop Chair

PART 1:  COMPARING ECONOMIC MODELS OF CRC SCREENING

9:30 – 11:00
Overview of  Five Leading Economic Models of CRC Screening

The “Miscan Model”: Marjolein van Ballegooijen, M.D., Erasmus University
The “Vijan Model”:  Sandeep Vijan, M.D., University of Michigan
The “Harvard Model”:  Karen Kuntz, Sc.D., Harvard University
The “Vanderbilt Model”:  Reid Ness, M.D., Vanderbilt University
The  “Ladabaum Model”:  Uri Ladabaum, M.D., University of California at San Francisco

11:00 – 11:15
Break

11:15 – 11:45
Results of a Pre-Workshop Comparative Modeling Exercise
Michael Pignone, M.D., University of North Carolina

11:45 – 12:45
Discussion

12:45 – 1:15
Lunch

PART II:  CURRENT EVIDENCE ON COLORECTAL CANCER SCREENING

1:15 – 2:30
Evidence on Compliance (Q&A follows presentations)

Current Evidence on Compliance 
Sally Vernon, Ph.D., University of Texas at Houston

Recent Follow-up and Compliance Patterns of Medicare Patients
Todd Anderson, M.S., Congressional Budget Office

The Relationship between Compliance and Capacity
Laura Seeff, M.D., Centers for Disease Control

2:30- 3:15
Recent Findings on Test Performance
Brian Mullhall, M.D., Walter Reed Army Hospital

3:15- 3:30
Break

3:30 -4:15
Measuring the Cost of Screening, Follow-up and Surveillance in Cost-Effectiveness Models
Martin Brown, Ph.D. National Cancer Institute

Q&A follows presentation

4:15 – 5:00
Evidence on Effectiveness of Follow-up and Surveillance Strategies
Deborah Schrag, M.D., Memorial Sloan Kettering Cancer Center

Q&A  follows presentation

Day 2

8:30 – 9:00
Defining Issues: A Reprise of First Day’s Findings
Martin Brown, Michael Pignone, Judith Wagner

PART III:  MODELING THE NATURAL HISTORY OF COLORECTAL CANCER

9:00 – 9:45
Recent Evidence on Natural History
T.R. Levin, M.D., Kaiser Permanente Division of Research

Q&A  follows presentation

9:45 – 10:00
The NCI CISNET Project:  An overview of Goals, Methods and Current Status
Eric Feuer, Ph.D., National Cancer Institute

10:00 – 10:15
Break

10:15- 11:15
Discussion of Issues in Modeling Natural History

11:15 – 12:00
Modelers’ Forum:  Next Steps, Unresolved Questions, Critical Information Needs
Marjolein van Ballegooijen , Karen Kuntz, Sandeep Vijan, Reid Ness, Uri Ladabaum and coauthors

12:00 – 1:00
Discussion and Wrap-up

1:00
Adjourn